The agreement covers mRNA, vector-based and protein-based vaccines and does not relate to existing COVID-19 vaccine agreements between the EU and vaccine makers including U.S.-based Pfizer. The European Commission has secured deals with Pfizer and several European drugmakers to reserve the capacity to make up to 325 million vaccines per year in case of a […]